featured
Outcomes in Patients With DLBCL Treated With Commercial CAR T Cells
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood Advances
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Outcomes in Patients With DLBCL Treated With Commercial CAR T Cells Compared With Alternate Therapies
Blood Adv 2020 Oct 13;4(19)4669-4678, D Sermer, C Batlevi, ML Palomba, G Shah, RJ Lin, MA Perales, M Scordo, P Dahi, M Pennisi, A Afuye, ML Silverberg, C Ho, J Flynn, S Devlin, P Caron, A Hamilton, P Hamlin, S Horwitz, E Joffe, A Kumar, M Matasar, A Noy, C Owens, A Moskowitz, D Straus, G von Keudell, I Rodriguez-Rivera, L Falchi, A Zelenetz, J Yahalom, A Younes, C SauterFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.